» Articles » PMID: 18551129

Unravelling the Association of Partial T-cell Immunodeficiency and Immune Dysregulation

Overview
Journal Nat Rev Immunol
Date 2008 Jun 14
PMID 18551129
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Partial T-cell immunodeficiencies constitute a heterogeneous cluster of disorders characterized by an incomplete reduction in T-cell number or activity. The immune deficiency component of these diseases is less severe than that of the severe T-cell immunodeficiencies and therefore some ability to respond to infectious organisms is retained. Unlike severe T-cell immunodeficiencies, however, partial immunodeficiencies are commonly associated with hyper-immune dysregulation, including autoimmunity, inflammatory diseases and elevated IgE production. This causative association is counter-intuitive--immune deficiencies are caused by loss-of-function changes to the T-cell component, whereas the coincident autoimmune symptoms are the consequence of gain-of-function changes. This Review details the genetic basis of partial T -cell immunodeficiencies and draws on recent advances in mouse models to propose mechanisms by which a reduction in T-cell numbers or function may disturb the population-dependent balance between activation and tolerance.

Citing Articles

Autoimmune hypothyroidism GWAS reveals independent autoimmune and thyroid-specific contributions and an inverse relation with cancer risk.

Reeve M, Kanai M, Graham D, Karjalainen J, Luo S, Kolosov N Res Sq. 2024; .

PMID: 39041034 PMC: 11261955. DOI: 10.21203/rs.3.rs-4626646/v1.


Defective LAT signalosome pathology in mice mimics human IgG4-related disease at single-cell level.

Joachim A, Aussel R, Gelard L, Zhang F, Mori D, Gregoire C J Exp Med. 2023; 220(11).

PMID: 37624388 PMC: 10457416. DOI: 10.1084/jem.20231028.


Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease.

Tanaka A, Maeda S, Nomura T, Llamas-Covarrubias M, Tanaka S, Jin L J Exp Med. 2022; 220(2).

PMID: 36454183 PMC: 9718937. DOI: 10.1084/jem.20220386.


Targeted treatment of autoimmune cytopenias in primary immunodeficiencies.

Pacillo L, Giardino G, Amodio D, Giancotta C, Rivalta B, Rotulo G Front Immunol. 2022; 13:911385.

PMID: 36052091 PMC: 9426461. DOI: 10.3389/fimmu.2022.911385.


ZAP70, too little, too much can lead to autoimmunity.

Ashouri J, Lo W, Nguyen T, Shen L, Weiss A Immunol Rev. 2021; 307(1):145-160.

PMID: 34923645 PMC: 8986586. DOI: 10.1111/imr.13058.